论文部分内容阅读
尼美舒利(Nimesulide)是由西德B-曼海姆公司开发的一种新型非甾抗炎镇痛药。1985年在意大利首次上市。研究表明,每天服用尼美利舒200～400mg对解除疼痛、发烧、慢性风湿性关节炎、骨关节炎、呼吸道炎症、耳鼻喉科疾病、软组织和口腔炎症、痛经、静脉炎、泌尿生殖器疾病及手术后疼痛均比安慰剂有效得多。一些比较性研究揭示,本药要比炎痛喜康、扑热息痛、消炎灵、萘普生、戊烯保泰松、酮布洛芬(Ketoprofen)及甲灭酸更有效。尼美舒利虽有非甾抗炎镇痛药物常有的
Nimesulide is a new non-steroidal anti-inflammatory analgesic developed by the West German company B-Mannheim. First listed in Italy in 1985. Studies have shown that taking nimesulide 200 ~ 400mg daily to relieve pain, fever, chronic rheumatoid arthritis, osteoarthritis, respiratory inflammation, ENT diseases, soft tissue and oral inflammation, dysmenorrhea, phlebitis, genitourinary diseases and Postoperative pain was more effective than placebo. Some comparative studies have revealed that the drug is more effective than piroxicam, paracetamol, antiphlogistic, naproxen, penteny phenylbutazone, ketoprofen and mefenamic acid. Nimesulide Although non-steroidal anti-inflammatory analgesics often